Skip to content

Exagen Inc. XGN Interest coverage

Interest coverage at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
6.4×+1.4×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-19.8×+48.3×
CareDx logo
CareDxCDNA
-2×-6.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
22.7×+17.6×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
36.1×-0.9×
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-13×-5.0×

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on trailing twelve months.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s interest coverage?
Exagen Inc. (XGN) reported interest coverage of -2.8× in Q1 2026.
How has Exagen Inc.'s interest coverage changed year-over-year?
Exagen Inc.'s interest coverage increased by 55.4% year-over-year, from -6.3× to -2.8×.
What is the long-term trend for Exagen Inc.'s interest coverage?
Over 5 years (2020 to 2025), Exagen Inc.'s interest coverage has grown at a -11.3% compound annual growth rate (CAGR), from -5.9× to -3.3×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.